Pra Health (PRAH) Stock News
NASDAQ:PRAH - Nasdaq -
PRAH Latest News, Press Relases and Analysis
Veradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research Network
Mentions: MDRX
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs. Interesting Facts: Toyota Motor (NYSE:TM) was the largest firm by market cap to set a new 52-...
Recap: PRA Health Sciences Q1 Earnings
Shares of PRA Health Sciences (NASDAQ:PRAH) fell after the company reported Q1 results. Quarterly Results Earnings per share were up 28.57% year over year to $1.35, which...
Here's Why You Should Retain PRA Health (PRAH) Stock for Now
Investors continue to be optimistic about PRA Health (PRAH) owing to its strategic alliances and solid CRO market prospects.
Avantor Stock Showing Improved Relative Strength After 350%-Plus Run In Little More Than A Year
In terms of fundamentals, Avantor posted 106% EPS growth last quarter, to 35 cents a share. In the three preceding quarters its EPS grew 19%, 60% and 53%.
Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.
PRA Health Sciences (PRAH) Q1 Earnings and Revenues Beat Estimates
PRA Health Sciences (PRAH) delivered earnings and revenue surprises of 0.75% and 9.22%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?